Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson’s Disease to the Clinic: The Investigator’s Perspective

There is much excitement around the use of advanced therapy medicinal products (ATMPs), including cell and gene treatments, in Parkinson’s disease (PD). However, taking an ATMP to clinical trials in patients with PD is complex. As such it is important from an investigator’s perspective that they ask...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, Roger A., Cutting, Emma V., Daft, Danielle M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543259/
https://www.ncbi.nlm.nih.gov/pubmed/33814466
http://dx.doi.org/10.3233/JPD-212563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543259/
https://www.ncbi.nlm.nih.gov/pubmed/33814466
http://dx.doi.org/10.3233/JPD-212563

Ejemplares similares